Lukes AS - Search Results

1

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study.

Archer DF, Stewart EA, Jain RI, Feldman RA, Lukes AS, North JD, Soliman AM, Gao J, Ng JW, Chwalisz K. Archer DF, et al. Among authors: lukes as. Fertil Steril. 2017 Jul;108(1):152-160.e4. doi: 10.1016/j.fertnstert.2017.05.006. Epub 2017 Jun 1. Fertil Steril. 2017. PMID: 28579415 Free article. Clinical Trial.

2

Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact.

Lukes AS, Kadir RA, Peyvandi F, Kouides PA. Lukes AS, et al. Fertil Steril. 2005 Nov;84(5):1338-44. doi: 10.1016/j.fertnstert.2005.04.061. Fertil Steril. 2005. PMID: 16275227 Review.

3

Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.

Lukes AS, Reardon B, Arepally G. Lukes AS, et al. Fertil Steril. 2008 Sep;90(3):673-7. doi: 10.1016/j.fertnstert.2007.07.1315. Epub 2007 Nov 14. Fertil Steril. 2008. PMID: 18001734 Free article.

4

Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial.

Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, Richter HE, Eder SE, Attia GR, Patrick DL, Rubin A, Shangold GA. Lukes AS, et al. Obstet Gynecol. 2010 Oct;116(4):865-875. doi: 10.1097/AOG.0b013e3181f20177. Obstet Gynecol. 2010. PMID: 20859150 Clinical Trial.

5

Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding.

Lukes AS, Muse K, Richter HE, Moore KA, Patrick DL. Lukes AS, et al. Curr Med Res Opin. 2010 Nov;26(11):2673-8. doi: 10.1185/03007995.2010.526098. Epub 2010 Oct 13. Curr Med Res Opin. 2010. PMID: 20942615 Clinical Trial.

6

The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.

Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. Munro MG, et al. Int J Gynaecol Obstet. 2018 Dec;143(3):393-408. doi: 10.1002/ijgo.12666. Epub 2018 Oct 10. Int J Gynaecol Obstet. 2018. PMID: 30198563 Free article.

7

Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.

Liu JH, Soper D, Lukes A, Gee P, Kimble T, Kroll R, Mallick M, Chan A, Gillard P, Harrington A, Sniukiene V, Shulman LP. Liu JH, et al. Obstet Gynecol. 2018 Nov;132(5):1241-1251. doi: 10.1097/AOG.0000000000002942. Obstet Gynecol. 2018. PMID: 30303900 Clinical Trial.

8

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.

Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: lukes as. N Engl J Med. 2021 Feb 18;384(7):630-642. doi: 10.1056/NEJMoa2008283. N Engl J Med. 2021. PMID: 33596357 Free PMC article. Clinical Trial.

9

Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.

Stewart EA, Lukes AS, Venturella R, Arjona Ferreira JC, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Stewart EA, et al. Among authors: lukes as. Obstet Gynecol. 2022 Jun 1;139(6):1070-1081. doi: 10.1097/AOG.0000000000004787. Epub 2022 May 2. Obstet Gynecol. 2022. PMID: 35675604 Clinical Trial.

10

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.

Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: lukes as. Obstet Gynecol. 2022 Dec 1;140(6):920-930. doi: 10.1097/AOG.0000000000004988. Epub 2022 Nov 2. Obstet Gynecol. 2022. PMID: 36357960 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page